Comment from PCCA and NCPA
AnonymousOtherTrade association
Summary: The Pharmaceutical Compounding Centers of America (PCCA) and the National Community Pharmacy Association (NCPA) are responding to the FDA's request for clarification regarding the nomination of ammonium tetrathiomolybdate. They have decided not to pursue the substance for consideration on the 503A Bulk Drug Substances List.
This comment is in response to FDA's request for clarification for the nomination of ammonium tetrathiomolybdate to the 503A Bulk Drug Substances list. The attached comments are on behalf of both PCCA and NCPA.